Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma. 2001

H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
Department of Surgery, Toyama Prefectural Central Hospital, Toyama, Japan. hkimura@sun1.tch.pref.toyama.jp

OBJECTIVE Both thymidine phosphorylase (dThdPase) and vascular endothelial growth factor (VEGF) are well-characterized inducers of angiogenesis. The purpose of this study was to examine the expression of these antigens and their prognostic significance in gastric carcinoma. METHODS Medical records of 102 patients with stage II tumor were retrospectively reviewed. Primary tumors were studied by immunohistochemical staining for dThdPase and VEGF. RESULTS Positive dThdPase expression was observed in 52 (51%) tumors and positive VEGF expression in 53 (52%) tumors. There was a significant correlation between the positive expression of VEGF and lymphatic invasion. The patients with dThdPase-positive carcinoma showed a significantly worse prognosis than those with dThdPase-negative carcinoma in stage II. Moreover, the frequency of hepatic recurrence was significantly higher in the patients with dThdPase-positive and VEGF-positive tumors than in those with dThdPase-negative and VEGF-negative tumors. CONCLUSIONS Combination analysis of dThdPase and VEGF expression in gastric carcinoma appears to be well-characterized inductors of prognosis and metastasis.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
January 1999, Anticancer research,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
July 2003, World journal of gastroenterology,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
July 2000, British journal of cancer,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
November 1996, Cancer letters,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
December 2005, World journal of surgery,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
December 2011, Journal of cancer research and clinical oncology,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
January 2004, Anticancer research,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
March 1996, Cancer,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
January 2000, Oncology reports,
H Kimura, and K Konishi, and T Nukui, and M Kaji, and K Maeda, and K Yabushita, and M Tsuji, and A Miwa
September 1999, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!